Ventyx Biosciences Inc’s recent filing unveils that its CHIEF SCIENTIFIC OFFICER Nuss John unloaded Company’s shares for reported $29682.0 on Dec 19 ’24. In the deal valued at $2.26 per share,13,161 shares were sold. As a result of this transaction, Nuss John now holds 485,701 shares worth roughly $1.14 million.
Then, Nuss John bought 13,161 shares, generating $29,682 in total proceeds.
Before that, Mohan Raju bought 261,752 shares. Ventyx Biosciences Inc shares valued at $524,944 were divested by the CEO AND PRESIDENT at a price of $2.01 per share. As a result of the transaction, Mohan Raju now holds 2,175,028 shares, worth roughly $5.11 million.
Wells Fargo upgraded its Ventyx Biosciences Inc [VTYX] rating to an Overweight from a an Equal weight in a research note published on March 12, 2024; the price target was increased to $16 from $7. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in mid March from “a Perform” to “an Outperform”. Wells Fargo also remained covering VTYX and has decreased its forecast on November 07, 2023 with a “an Equal weight” recommendation from previously “an Overweight” rating. Stifel revised its rating on November 07, 2023. It rated VTYX as “a Hold” which previously was an “a Buy”.
Price Performance Review of VTYX
On Monday, Ventyx Biosciences Inc [NASDAQ:VTYX] saw its stock jump 4.91% to $2.35. Over the last five days, the stock has gained 4.44%. Ventyx Biosciences Inc shares have fallen nearly -4.86% since the year began. Nevertheless, the stocks have risen 5.86% over the past one year. While a 52-week high of $11.48 was reached on 03/08/24, a 52-week low of $1.67 was recorded on 11/21/24. SMA at 50 days reached $2.30, while 200 days put it at $3.22.
Levels Of Support And Resistance For VTYX Stock
The 24-hour chart illustrates a support level at 2.27, which if violated will result in even more drops to 2.19. On the upside, there is a resistance level at 2.41. A further resistance level may holdings at 2.46. The Relative Strength Index (RSI) on the 14-day chart is 49.47, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.22, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.76%. Stochastics %K at 7.17% indicates the stock is a buying.
How much short interest is there in Ventyx Biosciences Inc?
A steep rise in short interest was recorded in Ventyx Biosciences Inc stocks on 2024-11-29, growing by 0.46 million shares to a total of 8.59 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 8.14 million shares. There was a rise of 5.3%, which implies that there is a positive sentiment for the stock.
